… The first group consisted of 29 consecutive patients seen at the Istituto G. Gaslini (IGG control
sample) between 2002 and 2006 who had 33 instances of active disease. Active disease …

Objective To develop criteria for the classification of macrophage activation syndrome (MAS)
in patients with systemic juvenile idiopathic arthritis (JIA). Methods A multistep process, …

Objective To evaluate the safety and efficacy of infliximab in the treatment of juvenile rheumatoid
arthritis (JRA). Methods This was an international, multicenter, randomized, placebo‐…

Objective Juvenile localized scleroderma is usually considered a disease that is confined to
the skin and subcutaneous tissue. We studied the prevalence and clinical features of …

… Lehmberg K, Pink I, Eulenburg C, Beutel K, Maul-Pavicic A, Janka G. Differentiating
macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemo…

Objectives To report methodology and overall clinical, laboratory and radiographic
characteristics for Henoch–Schönlein purpura (HSP), childhood polyarteritis nodosa (c-PAN), c-…

Objective To obtain international consensus around processes that support the delivery of
high‐quality care to patients with childhood‐onset systemic lupus erythematosus (SLE) based …

OBJECTIVE: Uveitis occurs in 10%-15% of patients with juvenile idiopathic arthritis (JIA). If
topical treatment fails, second-line agents are used to control the disease. However, some …

Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune disease,
represents a significant challenge for both diagnosis and treatment. Patients with SLE in …

Background To our knowledge, the characteristics and burden of childhood arthritis have
never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional study…